Home › Hypertrophic Cardiomyopathy › Missouri
Pag-aaral pangklinika para sa Hypertrophic Cardiomyopathy sa Missouri
3 pag-aaral para sa Hypertrophic Cardiomyopathy ang naghahanap ng mga kalahok sa mga site sa Missouri.
Opisyal na teksto ng pag-aaral (English)
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- St. Luke's Mid-America Heart Institute, Kansas City
- Washington University, St Louis
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT05489705Mavacamten to Aficamten Transition in Patients With Obstructive Hypertrophic Cardiomyopathy
- St. Luke's Hospital - Mid America Heart Institute, Kansas City
Nagre-recruitPhase 4
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update May 20, 2026 · NCT07600177A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
- Imbria Investigational Site, St Louis
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update May 18, 2026 · NCT07023614Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.